Rare diseases
Investigational molecules
Locations
Via Saluzzo 1 A, 10125 Turin, Italy
Research activity includes treatment approaches for relapsed multiple myeloma and relapsed/refractory multiple myeloma, with attention to disease control after prior therapy and options for patients with limited remaining treatment pathways.
The trial portfolio reflects a focus on therapeutic strategies for patients requiring additional lines of myeloma treatment in the setting of prior treatment exposure.
Fondazione European Myeloma Network Italy O.N.L.U.S. runs clinical trials in conditions such as Plasma cell myeloma, Plasma cell myeloma refractory, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
ItalyItalyItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
